Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous...
45 KB (4,175 words) - 04:23, 25 September 2024
president and CEO of Kite Pharma. Although founded in 2009, the company went public in June 2014. Based in Santa Monica, Kite Pharma is a commercial-stage...
22 KB (2,125 words) - 18:28, 12 September 2024
up kite, Kite, or kitę in Wiktionary, the free dictionary. A kite is a tethered heavier-than-air or lighter-than-air craft with wing surfaces. Kite or...
3 KB (465 words) - 18:05, 18 September 2024
million in 2015. In August 2017, the company announced it would acquire Kite Pharma for $11.9 billion, equating to $180 cash per share, a 29% premium over...
79 KB (7,676 words) - 19:06, 27 September 2024
to include T cell malignancies. It was developed by California-based Kite Pharma. Axicabtagene ciloleucel was awarded U.S. Food and Drug Administration...
19 KB (1,361 words) - 00:03, 22 September 2024
"Kite Pharma, Inc. Completes $50 Million Mezzanine Private Financing". MarketWatch. April 28, 2014. Retrieved April 29, 2014. "Kite Pharma (KITE) Files...
9 KB (860 words) - 09:29, 4 July 2024
leukemia (B-ALL), and axicabtagene ciloleucel (Yescarta), marketed by Kite Pharma originally for diffuse large B-cell lymphoma (DLBCL). There are now six...
83 KB (8,682 words) - 02:22, 1 September 2024
lymphocyte drug for the treatment of unresectable or metastatic melanoma. Kite Pharma Garber, Ken (7 August 2019). "Pursuit of tumor-infiltrating lymphocyte...
3 KB (196 words) - 16:10, 5 June 2024
of Kite Pharma". Retrieved 9 August 2012.[dead link] "Kite Pharma - Scientific Advisory Board". Kite Pharma. Retrieved 8 August 2012. Kite Pharma. Press...
14 KB (1,110 words) - 01:12, 11 September 2024
a clinical recommendation for routine CFTR gene therapy. In February Kite Pharma announced results from a clinical trial of CAR-T cells in around a hundred...
176 KB (18,162 words) - 23:14, 25 September 2024